A phase I clinical trial of malignant pleural mesothelioma treated with locally delivered autologous anti-FAP-targeted CAR T-cells

Authors: A. Curioni, Christian Britschgi, Stefanie Hiltbrunner, Lorenz Bankel, P. Gulati, Walter Weder, Isabelle Opitz, Olivia Lauk, Claudio Caviezel, Alexander Knuth, Christian Münz, C. Renner, Rolf A. Stahel, Ulf Petrausch - Annals of Oncology 2019 cited by 53